Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab.
Saved in:
| Title: | Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab. |
|---|---|
| Authors: | Stares, Mark1,2 (AUTHOR) mark.stares@ed.ac.uk, Doyle, Emma1 (AUTHOR), Chapple, Sally1 (AUTHOR), Raynes, George1 (AUTHOR), MacDonald, James1 (AUTHOR), Barrie, Colin1 (AUTHOR), Laird, Barry1,2 (AUTHOR), MacKean, Melanie1 (AUTHOR), Philips, Iain1,2 (AUTHOR) |
| Source: | Lung Cancer (01695002). Mar2024, Vol. 189, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 175766703 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Stares%2C+Mark%22">Stares, Mark</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> mark.stares@ed.ac.uk</i><br /><searchLink fieldCode="AR" term="%22Doyle%2C+Emma%22">Doyle, Emma</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chapple%2C+Sally%22">Chapple, Sally</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Raynes%2C+George%22">Raynes, George</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22MacDonald%2C+James%22">MacDonald, James</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Barrie%2C+Colin%22">Barrie, Colin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Laird%2C+Barry%22">Laird, Barry</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22MacKean%2C+Melanie%22">MacKean, Melanie</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Philips%2C+Iain%22">Philips, Iain</searchLink><relatesTo>1,2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Lung+Cancer+%2801695002%29%22">Lung Cancer (01695002)</searchLink>. Mar2024, Vol. 189, pN.PAG-N.PAG. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=175766703 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.lungcan.2024.107497 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Titles: – TitleFull: Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stares, Mark – PersonEntity: Name: NameFull: Doyle, Emma – PersonEntity: Name: NameFull: Chapple, Sally – PersonEntity: Name: NameFull: Raynes, George – PersonEntity: Name: NameFull: MacDonald, James – PersonEntity: Name: NameFull: Barrie, Colin – PersonEntity: Name: NameFull: Laird, Barry – PersonEntity: Name: NameFull: MacKean, Melanie – PersonEntity: Name: NameFull: Philips, Iain IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 01695002 Numbering: – Type: volume Value: 189 Titles: – TitleFull: Lung Cancer (01695002) Type: main |
| ResultId | 1 |